January 28, 2016 (Shareholders Foundation) - An investigation on behalf of investors of CIGNA Corporation (NYSE:CI) shares over potential securities laws violations by CIGNA and certain of its directors and officers in connection certain financial statements was announced.

The investigation by a law firm focuses on possible claims on behalf of purchasers of the securities of CIGNA Corporation (NYSE:CI) concerning whether a series of statements by CIGNA regarding its business, its prospects and its operations were materially false and misleading at the time they were made.

CIGNA Corporation reported that its annual Total Revenue rose from over $32.39 billion in 2013 to $34.95 billion in 2014 and that its Net Income increased from over $1.47 billion in 2013 to over $2.1 billion in 2014.

Shares of CIGNA Corporation (NYSE:CI) grew from $75.64 per share in April 2014 to as high as $168.06 per share in June 2015.

On January 22, 2016, CIGNA Corporation announced that on January 21, 2016 it was notified by the Centers for Medicare & Medicaid Services ('CMS') of its intent to impose intermediate sanctions suspending the enrollment of and marketing to new customers of all Cigna Medicare Advantage and Standalone Prescription Drug Plan Contracts.